CG Oncology, Inc. to unveil new data on CORE-008 Cohort CX for bladder cancer

Traders Union
All News
Business & Wealth
CG Oncology, Inc. unveils bladder cancer data

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Business & Wealth

Market Voices

Iryna Sazhynska

11.05.2026

CG Oncology, Inc. to unveil new data on CORE-008 Cohort CX for bladder cancer — CG Oncology, Inc. unveils bladder cancer data

CG Oncology, Inc. has announced its planned participation at the upcoming American Urological Association Annual Meeting, where it will present initial results from its CORE-008 Cohort CX study in bladder cancer.

This marks an important milestone for the company as it aims to advance research in bladder cancer treatment. CG Oncology, Inc. invited attendees to review these findings at #AUA26, aligning with its commitment to introducing new data to the urological community.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

CG Oncology, Inc. has recently focused on addressing the persistent risk of bladder cancer recurrence despite approved NMIBC therapies, according to a previous update. The company also reported its first quarter 2026 financial results alongside new urology business developments earlier this year in a separate announcement. These initiatives reflect an ongoing emphasis on research and development within the bladder cancer space.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

A thousand blockchain patents: Why Circle wants IBM’s portfolio

By Oleg Tkachenko
6 hours ago

A thousand blockchain patents: Why Circle wants IBM’s portfolio

Editors' Picks

Allbridge co-founder: Many people do not even realize they are using crypto bridges

By Eugene Komchuk
11 hours ago

Allbridge co-founder: Many people do not even realize they are using crypto bridges

Editors' Picks

Bitcoin mining is getting greener, but the debate isn't over

By Anastasiia Chabaniuk
Yesterday

Bitcoin mining is getting greener, but the debate isn't over

Editors' Picks

All Editors' Top Picks

Latest CG Oncology News

CG Oncology, Inc. unveils peer-reviewed clinical findings for advanced bladder cancer therapy

By Ivan Andriyenko
20 hours ago

CG Oncology, Inc. unveils peer-reviewed clinical findings for advanced bladder cancer therapy

Companies

CG Oncology appoints David Fela as vice president to strengthen quality control focus

By Oleg Tkachenko
23.07.2026

CG Oncology appoints David Fela as vice president to strengthen quality control focus

Companies

CG Oncology CEO Arthur Kuan to present at Jefferies and Goldman Sachs healthcare events

By Yaroslav Dmytrenko
29.05.2026

CG Oncology CEO Arthur Kuan to present at Jefferies and Goldman Sachs healthcare events

Companies

All CG Oncology News

Oleg Tkachenko
6 hours ago

A thousand blockchain patents: Why Circle wants IBM’s portfolio

Eugene Komchuk
11 hours ago

Allbridge co-founder: Many people do not even realize they are using crypto bridges

Anastasiia Chabaniuk
Yesterday

Bitcoin mining is getting greener, but the debate isn't over

Mikhail Vnuchkov
Yesterday

Asia's largest IPO: How CXMT became China's most valuable company

Pavlo Kot
26.07.2026

Global fintech in 2026: Three trends that matter

Hanna Syniavska
6 min ago

Peter Todd: Majority of Bitcoin nodes oppose BIP-110 by running Core software

Eugene Komchuk
12 min ago

Harry Stebbings: Mega outcomes in venture matter more than high ownership

Jose Antonio Gastelum
22 min ago

OKX introduces up to $500 BTC rewards for new users, Layah Heilpern states

Dmytro Kharkov
41 min ago

Oil prices decline over 4 percent and WTI dips under $80, Anas Alhajji notes

Parshwa Turakhiya
41 min ago

Gokul Rajaram: Growth rate decline means missed window for sale

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Olga Shendetskaya
4 hours ago

Apple rolls out Klarna-backed iPhone leasing

Apple rolls out Klarna-backed iPhone leasing

Ivan Andriyenko
6 hours ago

KOSPI halts trading amid global tech selloff

KOSPI halts trading amid global tech selloff

Igor Krasulya
7 hours ago

Coca-Cola raises 2026 outlook after strong quarter

Coca-Cola raises 2026 outlook after strong quarter

Hanna Syniavska
8 hours ago

Meta and BlackRock partner on Texas data center

Meta and BlackRock partner on Texas data center

Eugene Komchuk
10 hours ago

Musk begins U.S. rollout of X Money banking service

Musk begins U.S. rollout of X Money banking service

Top 5 companies for you

United States

Live News

Anton Kharitonov
Now

Alphabet selloff deepens as surging AI costs erode cash generation

Anton Kharitonov
Now

Microsoft stabilizes as AI demand offsets macro headwinds

Anton Kharitonov
Now

Apple extends rally as AI strategy and new Upgrade program strengthen ecosystem

Anton Kharitonov
Now

Bitcoin loses momentum as macro uncertainty caps recovery

Anton Kharitonov
Now

WTI slips as easing geopolitical premium shifts focus to supply

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.